Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
January 25, 2024 16:29 ET
|
Titan Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the...
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
December 28, 2023 16:15 ET
|
Titan Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a...
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
October 16, 2023 16:37 ET
|
Titan Pharmaceuticals, Inc.
SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") is pleased to announce the appointments of Dato’ Seow Gim Shen and Brynner...
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
September 18, 2023 07:30 ET
|
Titan Pharmaceuticals, Inc.
SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that it has entered into a definitive securities purchase...
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
July 27, 2023 07:30 ET
|
Titan Pharmaceuticals, Inc.
SAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into an Asset Purchase Agreement (the...
Titan Pharmaceuticals Provides Shareholder Update
December 15, 2022 07:00 ET
|
Titan Pharmaceuticals, Inc.
Signs Non-Binding Letter of Intent for Transformational TransactionContinues to Make Substantial Progress on Strategic Transactions Including Sale of Existing Assets SAN FRANCISCO, Dec. 15, 2022 ...
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
December 12, 2022 07:49 ET
|
Titan Pharmaceuticals, Inc.
SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has granted an exclusive license to Ocular Therapeutix...
Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
December 12, 2022 06:30 ET
|
Titan Pharmaceuticals, Inc.
SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has granted an exclusive license to Ocular Therapeutix...